Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Liquid Biopsy is Scopus-indexed (Q3, CiteScore 3.7), WoS ESCI, DOAJ. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2950-1954Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Oncology | 228 / 428 | 46th | Q3 |
| Genetics | 204 / 357 | 42nd | Q3 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2023–present, best quartile Q3, CiteScore 3.7.
Journal of Liquid Biopsy is Q3 in Oncology (rank 228 of 428) and Q3 in Genetics (rank 204 of 357), by CiteScore 2025.
Journal of Liquid Biopsy is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 3.7, which places it in quartile Q3 at the 46th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.832, quartile Q2, with an H-index of 9.
The publisher lists an article processing charge of about US$2,080 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Liquid Biopsy is published by Elsevier B.V. Its ISSN is 2950-1954.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Journal of Liquid Biopsy has an h-index of 17 and a 2-year mean of 3.11 citations per paper (OpenAlex). Its Scopus CiteScore is 3.7, quartile Q3. On 2-year citations it ranks #104 of 424 Scopus journals in Oncology.
Journal of Liquid Biopsy published 145 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 89 research articles (2025–2026), authors are most often from United States (31%), Italy (21.8%) and Spain (7.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (2.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.